Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study
Revista Española de Quimioterapia · 29.09.2026 · 39 (5) · 451
DOI: 10.37201/req/196.2026 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 29.09.2026. Verfasst von Lucía Gómez-Barral und 4 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología, Hospital Universitario de Salamanca, Salamanca, Spain. Hauptthemen laut MEDLINE: Antifungal Agents, Candida, Blood Culture. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To evaluate the agreement between direct gradient diffusion (DGD), performed directly from positive blood culture bottles, and the Sensititre™ YeastOne™ (SYO) method for antifungal susceptibility testing in Candida spp.
Methods
A prospective observational study including blood cultures positive for yeasts between June and October 2024 was conducted. DGD (ETEST®) was performed directly from blood culture broth and compared with SYO. The antifungal agents evaluated were anidulafungin, micafungin, caspofungin, fluconazole, voriconazole, and amphotericin B. Categorical agreement (CA) and essential agreement (EA) were analyzed.
Results
A total of 32 Candida isolates were included. Overall CA was 90%, whereas EA was 60.6%. CA was 100% for amphotericin B, 92.5% for azoles, and 86% for echinocandins. No very major errors were observed. However, all Candida parapsilosis isolates showed major errors for anidulafungin, appearing resistant by DGD and susceptible by SYO. All DGD results were interpretable after 24 hours.
Conclusions
DGD performed directly from positive blood culture bottles provides early antifungal susceptibility results with high CA and markedly reduced turnaround time. However, caution is required when interpreting anidulafungin resistance in C. parapsilosis. This approach may serve as an adjunctive tool for early optimization of antifungal therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Microbiología, Hospital Universitario de Salamanca, Salamanca, Spain.
- Research group IIMD-16, Instituto de Investigación Biomédica de Salamanca (IBSAL), SACYL, Universidad de Salamanca, CSIC, Salamanca, Spain.
- Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, Salamanca, Spain.
- Centro de Investigación en Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain. jlmubel@usal.es.
- Centro de Investigación en Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Salamanca, Spain.
ORCID-Profile: Lucía Gómez-Barral, Diego González-Polo, Blanca Burgoa-Rubido, Juan Luis Muñoz-Bellido, Josué Pendones-Ulerio
Zitieren
APA
Gómez-Barral, L., González-Polo, D., Burgoa-Rubido, B., Muñoz-Bellido, J. L., & Pendones-Ulerio, J. (2026). Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study. Revista Española de Quimioterapia, 39(5), 451. https://doi.org/10.37201/req/196.2026
Vancouver
Gómez-Barral L, González-Polo D, Burgoa-Rubido B, Muñoz-Bellido JL, Pendones-Ulerio J. Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study. Revista Española de Quimioterapia. 2026;39(5):451. doi:10.37201/req/196.2026
BibTeX
@article{GmezBarral2026,
author = {Gómez-Barral, Lucía and González-Polo, Diego and Burgoa-Rubido, Blanca and Muñoz-Bellido, Juan Luis and Pendones-Ulerio, Josué},
title = {Rapid antifungal susceptibility testing from positive blood cultures using direct gradient diffusion: a prospective study},
journal = {Revista Española de Quimioterapia},
year = {2026},
volume = {39},
number = {5},
pages = {451},
doi = {10.37201/req/196.2026}
}
EUVIMED